Navigation Links
Mortality Data Presented for Patients Treated with Effient® Who Underwent Isolated Coronary Artery Bypass Surgery
Date:11/16/2010

CHICAGO, Nov. 16, 2010 /PRNewswire-FirstCall/ -- New results from an observational substudy from TRITON–TIMI 38 presented today at the American Heart Association (AHA) Scientific Sessions annual meeting showed that patients treated with Effient® (prasugrel) prior to coronary artery bypass graft surgery (CABG) had a reduced overall mortality rate compared to patients treated with Plavix® (clopidogrel) (2.3 percent versus 8.7 percent respectively, p=0.016).(1)  

This retrospective analysis involved 346 patients with acute coronary syndrome (ACS) who had received either study drug and subsequently underwent isolated CABG at some point during the 15-month TRITON-TIMI 38 trial.(2)

In addition to all-cause mortality, this same analysis found that the risk-adjusted rate of cardiovascular death at 30 days was also lower in patients treated with Effient compared with those receiving clopidogrel (0.6 percent versus 5.8 percent respectively, p=0.038). (3) Effient-treated patients experienced a statistically significantly higher volume of chest tube blood loss at 12 hours post-CABG compared to the clopidogrel-treated patients (655 +/- 580 milliliters with Effient versus 503 +/- 378 milliliters with clopidogrel).(1)

"This analysis showed that Effient was associated with a significantly lower mortality rate compared with clopidogrel among these CABG patients but with a significantly higher risk of serious bleeding events," said Peter K. Smith, M.D., professor of surgery and division chief of Cardiovascular and Thoracic Surgery at Duke University Medical Center and lead investigator for the retrospective CABG analysis. "This analysis helps better define the risk of mortality for physicians who care for the ACS patients who may be targeted for percutaneous coronary intervention (PCI) but end up undergoing CABG instead."

The Effient prescribing information includes a warning and precaution against starting Effient in patients like
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Study Shows Use of AdvanDxs PNA FISH(TM) Test was Associated with an 82% Reduction in Intensive Care Unit Mortality Rates from Staphylococcus aureus Bloodstream Infections
2. n-3 PUFAs Reduce Mortality and Hospital Admissions in Patients With Symptomatic Heart Failure
3. Preliminary Data From Experimental Study Demonstrate Increased Mortality in Stroke Patients Treated With Epoetin Alfa
4. Unemployment, Health Care Spending Affect Mortality
5. Increased Mortality Associated With Nocturia
6. Two New Clinical Studies Show That Limited Exposure to Blood Transfusion Significantly Increases Morbidity and Mortality After Surgery
7. Analysis Shows Novartis Drug TOBI® Associated With Reduced Mortality in Cystic Fibrosis Patients With Common Lung Infection
8. Robotic Prostatectomy Expert Dr. David Samadi Talks About Big Strides in the Fight Against Prostate Cancer - Mortality Rate Declines 45%
9. Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity in Patients With Chronic Heart Failure With Mild Symptoms, Study Shows
10. Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... and PHOENIX , Aug. 20, ... bring cutting-edge next-generation sequencing and proteomic diagnostics and ... announced a collaboration with TESARO, Inc.  Paradigm will ... tissue samples from clinical trials to better predict ... TESARO,s TSR-011.  This may lead to more successful clinical ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com ... available in its catalogue: The Market ... http://www.reportlinker.com/p02051938/The-Market-for-Medical-Devices-in-EMEA .html The European, Middle Eastern and ... medical devices. As part of its coverage, this ... concentrates on the EMEA medical device markets and ...
(Date:8/20/2014)... 2014  Quantum Materials Corporation (OTCQB:QTMM) today announced ... families from Bayer Technology Services GmbH, the global technological ... of Leverkusen, Germany . ... property protection for advances Quantum Materials ... manufacturing. In addition, the Bayer patents cover volume ...
Breaking Medicine Technology:Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc. 2The Market for Medical Devices in EMEA 2The Market for Medical Devices in EMEA 3The Market for Medical Devices in EMEA 4The Market for Medical Devices in EMEA 5Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 2Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 3Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 4
(Date:8/20/2014)... 2014 Today, Zane Benefits, the ... of a new eBook, Affordable Care Act 101. ... owners feel uncertain about how the ACA impacts ... bottom line. , The new eBook outlines key ... navigate their upcoming health insurance decisions. , Read ...
(Date:8/20/2014)... 2014 Locating rates for insurance packages will ... Pros website. A new source of term life insurance providers ... good for all 50 states at http://quotespros.com/life-insurance.html . ... the new methods available for the public to find out ... supplied. The instant quotations that are available are good through ...
(Date:8/20/2014)... TUESDAY, Aug. 19, 2014 (HealthDay News) -- A group ... to get a flu shot. According to the ... released in recent years have upheld the safety and ... virus is highly infectious and can be particularly dangerous ... labor, and other complications," Dr. Laura Riley, chair of ...
(Date:8/20/2014)... Thompson HealthDay Reporter WEDNESDAY, ... has saved a group of rhesus monkeys from deadly Marburg ... up to 90 percent of those it infects, researchers report. ... of Marburg virus, even when it was given three days ... the journal Science Translational Medicine . This is ...
(Date:8/20/2014)... of women underwent breast reconstruction following a mastectomy ... reconstruction included being black, having a lower education ... M.D., of the Memorial Sloan Kettering Cancer Center, ... Health and Cancer Rights Act in 1998 guaranteed ... Still, most women who undergo a mastectomy do ...
Breaking Medicine News(10 mins):Health News:Term Life Insurance Price Database Now Helps Quote Prices for Adults in 50 States Online 2Health News:All Pregnant Women Need Flu Shot: Ob/Gyn Group 2Health News:Drug for Ebola-Like Virus Shows Promise in Monkeys 2Health News:Drug for Ebola-Like Virus Shows Promise in Monkeys 3Health News:Patient perspectives on breast reconstruction following mastectomy 2
... traumatic way of delivering surfactant, a lung lubricant that ... the incidence of respiratory problems theyll have later, Medical ... that while surfactant keeps the tiny air sacs inside ... deflate while breathing, the delivery method causes trauma to ...
... Layoffs and Loss of Healthcare Services, PRINCETON, N.J., ... drives and longer waits for care.,Those are among the ... state,s $300 million in proposed healthcare cuts are approved., ... healthcare leaders from across,the state met with Gov. Jon ...
... Heart Association advocates call on lawmakers to support,research ... risk factors for,heart disease and stroke steadily increasing, ... across the country today urged,Congress to make a ... for the American Heart Association,s (AHA) Congressional,Lobby Day, ...
... Colo., April 29 The Glendale Raptors Try,Rugby League (TRL) ... Rugby League as well as the sign-up and attendance,dates for ... The Youth TRL will run from May 6th - June ... coed, will be held every Tuesday,and Thursday from 5:00-6:30 pm ...
... with dangers , , TUESDAY, April 29 (HealthDay News) -- ... increase the risk of fatal coronary heart disease in ... produced by the pituitary gland, is released into the ... its growth and function. , "Emerging evidence indicates that ...
... 2 S) is a gas most commonly associated with the ... team of researchers from the Peninsula Medical School in the ... identified a role for this gas in regulating blood pressure, ... Circulation. , The research team has previously shown that H ...
Cached Medicine News:Health News:New treatment could reduce chronic lung disease in premature babies 2Health News:Hospital CEOs Meet with Governor on Budget Cuts 2Health News:Hundreds of Heart Disease and Stroke Survivors Urge Congress to Step Up the Fight Against the Nation's No. 1 Killer 2Health News:Hundreds of Heart Disease and Stroke Survivors Urge Congress to Step Up the Fight Against the Nation's No. 1 Killer 3Health News:The Glendale Raptors Set Dates for Youth Rugby League and USA Rugby Youth Academy 2Health News:Pituitary Hormone May Boost Women's Heart Risk 2Health News:'Rotten eggs' in the blood 2
... Aplicare's Saturated Swabsticks ... open, single-use foil-laminated pouches. ... is saturated with precisely ... solution. Each package is ...
BD Persist Plus protective barrier provides a one-step antimicrobial barrier with minimum of 1% chlorhexidine with Up to 7-day antimicrobial effectiveness....
... BD Persist contains 70% alcohol ... a unique polymer base, forming a ... creates a protective environment for the ... microorganisms most commonly associated with catheter ...
The design of the new ChloraPrep swabstick applicator provides significant improvement in performance over traditional swabsticks....
Medicine Products: